Shoulder surgery showdown: does removing a tiny bone fragment boost recovery?

NCT ID NCT07604714

Disease control Sponsor: Clinique Générale dAnnecy Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Aug 20, 2026 · Updated 3 times

Summary

This study tests whether removing a small part of the shoulder bone (coracoid) during reverse total shoulder replacement helps patients rotate their arm inward better after surgery. Sixty adults needing shoulder replacement will be randomly assigned to get the standard surgery or the surgery with the extra bone removal. The main goal is to see if the added step improves daily activities like reaching behind the back at one year after surgery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance: surgical procedure (reverse total shoulder arthroplasty with or without partial coracoidectomy)
What this could lead to: If successful, this could show that removing a small part of the shoulder bone during surgery improves a patient's ability to rotate their arm inward after recovery.
What could go wrong: This is a small, early-stage trial with only 60 participants, so results may not apply to everyone. The added procedure could also increase surgical risks like infection or nerve damage.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2026

Expected to finish

Apr 2030

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: \- Adults undergoing reverse total shoulder arthroplasty (rTSA), including primary procedures or fracture repair. Indications may include arthropathy due to a rotator cuff tear, primary glenohumeral osteoarthritis with an irreparable rotator cuff tear, or post-traumatic arthritis. Exclusion Criteria: * Patients with a history of coracoid fractures or who have previously undergone surgery involving the coracoid process. * Patients undergoing latissimus dorsi transfers * Presence of an active infection, inflammatory arthritis, or a tumor affecting the shoulder region. * Patients with pre-existing neuromuscular disorders affecting shoulder function * Patients who are unwilling or unable to participate in the trial or complete follow-up assessments * Patients deprived of their liberty by judicial or administrative order, in pretrial detention, or under guardianship, conservatorship, or judicial protection. * Pregnant women, women in labor, or breastfeeding women * Patients receiving psychiatric care * Patients not enrolled in a social security program

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Primary glenohumeral osteoarthritis with irreparable rotator cuff tear are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

osteoarthritis rotator cuff syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Reverse total shoulder arthroplasty

How to take part

Only the study team decides who joins. These are the ways to reach them.

The places running it

1 site. The list below names each one and where it is.
The official record

ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

Open the record ↗
A doctor treating you

A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Shoulder surgery showdown: does removing a tiny bone fragment boost recovery?

What the study statuses mean